antisense therapeutics ltd.[ASX:ANP / OTC:ATHJY]Antisense Therapeutics (ASX:ANP & OTC:ATHJY) is an Australian publicly traded biopharmaceutical drug discovery and development company focused on development and commercialisation of novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis and Acromegaly. The products are in-licensed from Ionis Pharmaceuticals Inc. (NASDAQ:IONS), world leaders in antisense drug development and commercialisation. The Company is undertaking a clinical trial of ATL1102 in patients with DMD. The Company recently reported positive clinical results following completion of dosing of all patients in the trial.
https://www.sachsforum.com/3nif-presenters.html
- Forums
- ASX - By Stock
- Ann: ANP to Present at Neuroscience Innovation Forum in the US
antisense therapeutics ltd.[ASX:ANP / OTC:ATHJY]Antisense...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.6¢ |
Change
0.005(6.17%) |
Mkt cap ! $77.53M |
Open | High | Low | Value | Volume |
8.2¢ | 8.7¢ | 8.2¢ | $93.35K | 1.100M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 228136 | 8.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.6¢ | 18794 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 228136 | 0.084 |
2 | 86585 | 0.082 |
2 | 37321 | 0.081 |
5 | 335350 | 0.080 |
4 | 61541 | 0.079 |
Price($) | Vol. | No. |
---|---|---|
0.086 | 18794 | 1 |
0.087 | 119524 | 2 |
0.088 | 457142 | 2 |
0.089 | 295000 | 3 |
0.090 | 265111 | 5 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |